FDA gives thumbs up to Trump's budget proposal

The US Food and Drug Administration has issued an approving statement relating to President Donald Trump’s budget proposal, noting the inclusion of “about $400 million in additional funding,” which would in part “further promote innovation and competition.”

FDA Commissioner Scott Gottlieb said the initiatives in question would help advance drug and device competition and create more modern, US-based manufacturing, “including continuous manufacturing of drugs and biological products, including vaccines.”

The Commissioner provided a list of projects that the funding would, if approved, be used to support.